Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label,... by Niemann, Carsten U, MD PhD, Munir, Talha, MBBS, Moreno, Carol, MD, Owen, Carolyn, MD, Follows, George A, Prof, Benjamini, Ohad, MD, Janssens, Ann, Prof, Levin, Mark-David, MD, Robak, Tadeusz, Prof, Simkovic, Martin, MD PhD, Voloshin, Sergey, Prof, Vorobyev, Vladimir, PhD, Yagci, Munci, Prof, Ysebaert, Loic, Prof, Qi, Keqin, PhD, Qi, Qianya, PhD, Sinet, Pierre, PharmD, Parisi, Lori, MPH, Srinivasan, Srimathi, PhD, Schuier, Natasha, MD, Baeten, Kurt, PhD, Howes, Angela, PhD, Caces, Donne Bennett, MD PhD, Kater, Arnon P, Prof

Get full text